Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Sept 2026 for Madrigal Pharmaceuticals, INC., €2.4M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
William Sibold: trading record in brief
William Sibold discloses dealings in Madrigal Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 20 July 2026 to 11 September 2026, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 11 September 2026: a transaction of €2.4M, in Madrigal Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Sibold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
5,221 shares@ US$533.12CommonSEC144:0001950047-26-009360
2,500 shares@ US$553.480.011% mcap100.0% of flowCommon StockSEC144:0001628280-26-048913
2 of 2 declarations
